WYMM Tour: Munich

February 27, 2024, 10:00 AM - 5:00 PM
Munich, Germany

WYMM Tour: Munich

27 February 2024, 10:00 - 16:45 CET - Munich, Germany

Generate ultra-rich data for answers with impact.

Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.​​

Join us on Tuesday 27th February 2024 in Munich to hear from local experts who are breaking new ground in human genomics, using nanopore technology.​​​

What you're missing matters. Stay on top of what's next.​

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.

Agenda

Agenda

10:00 – 18:00 hrs CET

Agenda (subject to change)

10:00 – 10:45 hrs

Registration, breakfast and networking

10:45 – 11:10 hrs

What you're missing matters: Catching the unnoticed

Tonya McSherry, Oxford Nanopore Technologies

11:10 – 11:35 hrs

Rare diseases: beyond the exome

Olaf Riess, University of Tubingen

11:35 – 12:00 hrs

Cancer methylome analysis with Oxford Nanopore Technologies - what a pathologist misses

Jürgen Hench, University Hospital Basel

12:00 – 13:15 hrs

Lunch

13:15 – 13:40 hrs

Oxford Nanopore Technologies bioinformatics update

Philipp Rescheneder, Oxford Nanopore Technologies

13:40 – 14:05 hrs

Nanopore sequencing enables detection of enhancer hijacking with allele-specific methylation

Etienne Sollier & Marvin Mayer, DKFZ

14:05– 14:30 hrs

Nanopore sequencing applied to RNA and infection research

Redmond Smyth, Helmholtz Institute for RNA-based Infection Research

14:30 – 15:30 hrs

Networking session

15:30 – 16:05 hrs

Panel discussion: The future of nanopore sequencing in clinical research

Moderated by Katrin Mansperger, Oxford Nanopore Technologies

16:05 – 16:35 hrs

Genetic and epigenetic profiling of repeat disorders using nanopore sequencing

Morghan Lucas, Medical Genetic Center (MGZ) Munich & LMU Clinic

16:35 – 16:45 hrs

Closing remarks

Oxford Nanopore Technologies

16:45 – 18:00 hrs

Drinks reception

Speakers

picture of Olaf Riess

Beyond the exome

Olaf Riess, University of Tubingen

Prof Riess, MD, is full professor for Medical Genetics, director of the Institute of Medical Genetic...

picture of Jürgen Hench

Cancer methylome analysis with Oxford Nanopore Technologies - what a pathologist misses

Jürgen Hench, University Hospital Basel

Board-certified neuropathologist with a specific focus on molecular (neuro)pathology Working at Uni...

picture of Etienne Sollier

Nanopore sequencing enables detection of enhancer hijacking with allele-specific methylation

Etienne Sollier, DKFZ

I got an Engineer's degree from Ecole Polytechnique (Paris, France) and a MSc in Bioinformatics from...

picture of Marvin Mayer

Investigating the multimodal epigenetic landscape of Acute Myeloid Leukemia with Nanopore sequencing

Marvin Mayer, DKFZ Heidelberg

Born and rooted in Heidelberg, I am currently in the final stages of my Master's degree in Molecular...

picture of Morghan Lucas

Genetic and epigenetic profiling of repeat disorders using nanopore sequencing

Morghan Lucas, Medical Genetic Center (MGZ) Munich & LMU Clinic

Morghan Lucas is the co-lead of R&D at the Medical Genetics Centre (MGZ) Munich and a visiting scien...

picture of Redmond Smyth

Nanopore sequencing applied to RNA and infection research

Redmond Smyth, Helmholtz Institute for RNA-based Infection Research (HIRI)

Born in Ireland, Redmond studied Natural Sciences (University of Cambridge, United Kingdom), special...